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Abstract—A correntropy-based technique is proposed for the
characterization and classification of respiratory flow signals in
chronic heart failure (CHF) patients with periodic or nonperiodic
breathing (PB or nPB, respectively) and healthy subjects. The cor-
rentropy is a recently introduced, generalized correlation measure
whose properties lend themselves to the definition of a correntropy-
based spectral density (CSD). Using this technique, both respira-
tory and modulation frequencies can be reliably detected at their
original positions in the spectrum without prior demodulation of
the flow signal. Single-parameter classification of respiratory pat-
terns is investigated for three different parameters extracted from
the respiratory and modulation frequency bands of the CSD, and
one parameter defined by the correntropy mean. The results show
that the ratio between the powers in the modulation and respi-
ratory frequency bands provides the best result when classifying
CHF patients with either PB or nPB, yielding an accuracy of 88.9%.
The correntropy mean offers excellent performance when classify-
ing CHF patients versus healthy subjects, yielding an accuracy of
95.2% and discriminating nPB patients from healthy subjects with
an accuracy of 94.4%.
Index Terms—Autoregressive (AR) modeling, chronic heart fail-
ure (CHF), correntropy spectral density (CSD), linear classifica-
tion, periodic breathing (PB).
I. INTRODUCTION
CHRONIC HEART FAILURE (CHF) is a serious healthproblem with a prevalence of 2% of the U.S. population,
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almost 5 million people are affected, and 30% to 40% of all
patients die within one year after diagnosis [1], [2]. The CHF
is associated with major abnormalities of autonomic cardiovas-
cular control, and this group of patients often develop breathing
anomalies such as various forms of oscillatory breathing pat-
terns characterized by rises and falls in ventilation. Periodic
breathing (PB) patterns can be classified into ventilation with
apnea, known as Cheyne–Stokes respiration (CSR), and ven-
tilation without apnea [3], [4]. PB has a prevalence as high
as 70% in CHF patients [5], and is associated with increased
mortality [6], especially in CSR patients [7], [8]. The breathing
patterns are also influenced by wakefulness or sleep, posture,
as well as physiological and mental activity [9]. Physiological
parameters for the characterization and detection of different
breathing patterns have been suggested in a number of recent
clinical studies [10], [11].
Certain studies relate CHF to alterations in the breathing pat-
tern [12]. For example, the sleep-disordered breathing parameter
is associated with an accelerated decline in cardiac function and
increased morbidity and mortality [13] in up to 50% of patients
with CHF [14]. Several studies suggest that central sleep apnea
is highly prevalent among patients with CHF, and the treatment
of this sleep-disordered breathing by continuous positive airway
pressure could be an important nonpharmacologic complement
to conventional drug therapy [15], [16]. In patients with mild
to severe CHF, the power of cardiovascular oscillations at the
very low frequency band has been reported to be considerably in-
creased by the presence of PB, which may distort prognosis [17].
Evidence that links exercise capacity to outcome in CHF pa-
tients has led to the use of peak oxygen consumption, derived
from maximal cardiopulmonary exercise testing, and the ex-
ertional oscillatory ventilation index in prognostic assessment.
However, these two indexes have certain limitations because of
the heterogeneity and complexity of the syndrome [18].
In order to develop new quantitative parameters, our initial
studies were focused on the periodicity of the respiratory pat-
tern through the modulation of the respiratory flow signal. The
relevant frequency band determined by the frequency peak of
the power spectral density (PSD) related to the envelope of the
respiratory flow signal was characterized [19], [20]. However,
not only is the respiratory modulation frequency essential when
studying PB and nPB patterns, respectively, but so is the respi-
ratory frequency.
The correlation function is probably the most widely utilized
function in signal processing for quantifying the similarity of
0018-9294/$26.00 © 2010 IEEE
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two random variables. However, as it only considers second-
order statistics, the success of this measure depends on the
assumption of Gaussian random variables. Santamaria et al. re-
cently introduced a generalization of the correlation function for
stochastic processes, which was called correntropy [21], [22].
Correntropy is a similarity measure defined in terms of inner
products of vectors in a kernel parameter space. It involves a
positive definite kernel function, which implicitly transforms
the original signal into a high-dimensional space in a nonlinear
way and calculates efficiently the generalized correlation in that
space. This measure, being directly related to Renyi’s quadratic
entropy estimate of data using Parzen windowing, contains in-
formation on both the time structure and the statistical distribu-
tion of the underlying dataset, consisting of the information of
higher order moments of the data. The ability to reflect nonlinear
characteristics of the signal makes correntropy a well-qualified
candidate for characterization of nonlinear dynamics. Another
attractive property of the correntropy function is its robustness
against impulsive noise. Besides, the use of kernel methods
makes the correntropy computationally efficient since it can be
computed directly from the data.
The aim of the present paper is to study the respiratory flow
signal in CHF patients with PB and nPB patterns in order to
define parameters, which can improve prognosis and serve as
indicators of a patient’s condition. The correntropy involves in-
formation on higher order statistics, which can be expected to
facilitate the detection of respiratory nonlinearities that conven-
tional techniques, based on second-order statistics, are otherwise
unable to do.
This paper is organized as follows. Section II briefly describes
the correntropy function and the related parametric version of
the correntropy-based spectral density (CSD); also, the set of
parameters which characterizes the flow signals is described.
Section III presents the datasets investigated for performance
evaluation, constituted by both real and simulated signals. The
classification results are presented in Section III and then dis-
cussed in Section IV.
II. METHODS
A. Correntropy: Definition and Estimation
For a discrete-time, strictly stationary stochastic process
x(n), n = 0, . . . , N − 1, N being the number of samples, the
correntropy function V (m) is defined as [21], [23]
V (m) = E[κ(x(n), x(n−m))] (1)
where E[·] is the statistical expectation operator and κ(·) is a
symmetric, positive definite kernel function. In this study, the
centered correntropy function Vc(m) is employed in which the
mean of the transformed data is subtracted so as to reduce the
effect of output dc bias [23], [24]. Its definition is given by
Vc(m) = Ex(n)x(n−m ) [κ(x(n), x(n−m))]
− Ex(n)Ex(n−m ) [κ(x(n), x(n−m))] (2)
where Ex(n)Ex(n−m ) [κ(x(n), x(n−m)] is the square mean of
the transformed data, corresponding to the correntropy mean
value (V ), which can be estimated through the kernel function
from the original data
V =
1
N 2
N∑
n=1
N∑
n=1
κ(x(n), x(n−m)). (3)
In the literature, the sigmoidal, Gaussian, polynomial, and
spline kernels are among the most commonly used symmetric
positive definite kernel functions. They are found in diverse
areas such as machine learning, function approximation, density
estimation, and support vector machine classification [25], [26].
The Gaussian kernel function, applied in the present study, is
given by
κ(x(n), x(n−m)) = 1√
2πσ
exp
[
− (x(n)− x(n−m))
2
2σ2
]
(4)
where σ is referred to as the kernel parameter “standard devia-
tion.” With the Taylor series expansion of the Gaussian kernel,
we can rewrite the correntropy function as
V (m) =
1√
2πσ
∞∑
k=0
(−1)k
2σ2kk!
E[(x(n)− x(n−m))2k ] (5)
containing all even-order moments of the random variable
(x(n)− x(n−m)).
Different kernel functions would yield different expansions,
but all kernel functions mentioned earlier are nonlinear and
therefore include higher order statistical information about the
stochastic process. From (5), it is obvious that the emphasis
given to higher order moments is controlled by σ. In this study,
σ is determined by Silverman’s rule of density estimation [21]:
σ = 0.9AN−1/5 (6)
where A is the smaller value of the standard deviation of data
samples and the data interquartile range scaled by 1.34, and
N is the number of samples. Since the flow signals are scalar,
this rule is simple to apply and is known to produce reasonable
values.
The flow signals sometimes contain missing samples or be-
come saturated, and consequently such samples must be dis-
carded from subsequent analysis as they do not reflect respira-
tory activity. The samples to be discarded are easily detected
however, and are here represented by the binary function g(n),
defined by
g(n) =
{ 1 existing
0 discarded. (7)
Information on discarded samples is introduced in the corren-
tropy estimator in a way similar to the sample estimator of the
correlation function [27]. Hence, the sample estimator of V (m)
in (1) is given by
Vˆ (m) =
1
U(m)
N∑
n=m
κ(x(n), x(n−m))g(n)g(n−m) (8)
where
U(m) =
N∑
n=m
g(n)g(n−m). (9)
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The results of this study are therefore based on the centered
correntropy, estimated by Vˆc(m) = Vˆ (m)− V .
In addition to the aforementioned signal problems, a variety
of other artifacts can be observed in flow signals. In general,
these problems have called for various preprocessing algorithms
that condition the acquired signal. A powerful advantage of the
correntropy is its robustness against impulsive noise, which is
due to that the Gaussian kernel makes κ(x(n), x(n−m)) ≈ 0
when either x(n) or x(n−m) is an outlier. Because of this
attractive property, the results of the present study were obtained
without any kind of preprocessing.
B. Correntropy Spectral Density
Similar to the conventional correlation function, it can be
shown that the correntropy function is positive definite and
therefore lends itself for use in many signal processing tech-
niques. Since we are particularly interested in exploring the
spectral properties of respiratory flow signals, the CSD is in-
troduced, being a generalization of the conventional PSD [21].
The CSD is based on the Fourier transform of the correntropy
function, i.e.
Pˆx(ejω ) =
N−1∑
m=−(N−1)
Vˆc(m)e−jωm . (10)
Considering that the flow signal is oscillatory in nature with a
spectrum that exhibits pronounced peaks, autoregressive (AR)
spectral analysis is here applied as it offers better spectral resolu-
tion than does periodogram-based spectral analysis. The corren-
tropy extension to a parametric CSD, assuming that the signal
is characterized by an AR model, is straightforward because the
correlation properties are preserved.
In this study, it is essential to have high spectral resolution
in the vicinity of the respiratory and modulation peaks; and
therefore, the following procedure was adopted. First, the opti-
mum order was determined in each subject using the minimum
description length criterion [28]. Then, the maximum of the re-
sulting model order estimates was selected and used as global
model order in the subsequent signal analysis. This model order
ensures a correct representation of the data when the prediction
error is a white sequence. We apply an statistical test (Ljung–
Box) to prove the whiteness of the prediction error.
The AR coefficients can be estimated from the correntropy
function, using the Yule–Walker equations, applied here, or any
other of the many well-known estimation techniques [29]. This
can be done because of the fact that the correntropy matrix,
whose elements are defined by Vˆc(m), is Toeplitz and positive
definite, just as the conventional correlation matrix [21].
C. Parameter Extraction
In the time domain, the respiratory pattern is characterized by
the correntropy mean, i.e., Renyi’s entropy. In the frequency do-
main, three parameters are derived from two different CSD fre-
quency bands centered either around the respiratory frequency
(∆fr : the respiratory frequency bandwidth) or the modulation
frequency (∆fm : the modulation frequency bandwidth). The
TABLE I
PARAMETER DESCRIPTION
modulation frequency of PB patterns ranges typically from
0.005 to 0.05 Hz, and the modulation frequency peak (fpm )
is located in this band with ∆fm = 0.02 Hz. The respiratory
frequency peak (fpr ) is tracked in the band from 0.2 to 0.4 Hz
with ∆fr = 0.2 Hz. The individual powers of the two frequency
bands Pm and Pr and their ratio R = Pm/Pr constitute the
three spectral parameters, which are investigated in this study,
see Table I.
III. EXPERIMENTAL PROTOCOL AND DATA ANALYSIS
A. Datasets
Respiratory flow signals were recorded from 35 healthy vol-
unteers (23 female, 27 ± 7 years, respiratory frequency 15.5 ±
3.7 breaths/min) and 26 CHF patients (7 female, 65 ± 9 years,
19.6 ± 3.4 breaths/min) at Santa Creu i Sant Pau Hospital,
Barcelona, Spain. All subjects were studied according to a pro-
tocol approved by the local Ethics Committee. The respiratory
flow signals were acquired using a pneumotachograph, consist-
ing of a Datex-Ohmeda monitor with a Validyne Model MP45-
1-871 Variable-Reluctance Transducer. The pneumotachograph
was connected to a mask. The signals were recorded at 250-Hz
sampling rate and 12-bit resolution.
The same patient might present a mixture of breathing pat-
terns, ranging from normal breathing (without cyclic modulation
of ventilation) through mild PB to CSR patterns. The respiratory
flow signals of CHF patients were acquired during a checkup.
Prior to data acquisition, a few minutes of adaptation were al-
lowed in order to make the subjects feel comfortable with the
mask. The respiratory flow signals were acquired during 15 min
in both CHF patients and healthy subjects. All subjects were
seated and remained awake throughout acquisition.
The classification of the CHF patients (PB, nPB, and CSR)
was developed by the medical doctors at the Santa Creu i Sant
Pau Hospital, Barcelona, Spain. The CHF patients were classi-
fied into two groups: eight patients with PB patterns (1 female,
71 ± 7 years, 18.4 ± 2.2 breaths/min), and 18 patients with
nPB pattern (5 female, 62 ± 9 years, 22.5 ± 4.3 breaths/min).
Within the PB group, three patients were classified as CSR
(1 female, 68 ± 6 years, 21.7 ± 4.2 breaths/min) and five pa-
tients as PB without apnea (no females, 73 ± 8 years, 23.0 ±
4.7 breaths/min). Fig. 1 illustrates the different flow patterns
observed in CSR, PB, nPB patients, and a healthy subject.
For the 61 subjects, the respiratory frequency was found to
range from 0.2 to 0.4 Hz, and the modulation frequency from
0.01 to 0.04 Hz. These frequency ranges are in good agreement
with those earlier reported by Pinna et al. [9].
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Fig. 1. Respiratory flowsignal exemplified for (a) a CSR patient, (b) a PB
patient, (c) a nPB patient, and (d) a healthy subject.
Fig. 2. (a) Respiratory flow signal acquired from a PB patient, and (b) a
simulated AM signal with 0.3-Hz carrier (“respiratory”) frequency, 0.02-Hz
modulation frequency, and µ = 0.8.
The flow signals were decimated from 250 to 2 Hz, using
null-phase antialiasing filtering, to account for the fact that the
frequencies of interest only ranges up to about 0.5 Hz; oversam-
pling is of particular importance to avoid when performing AR
spectral analysis [30].
B. Simulated Data
The behavior of the respiratory flow signal in PB patients of-
ten resembles that of a signal subjected to amplitude modulation
(AM). In order to illustrate certain properties of the method’s
performance, the following AM signal is studied
x(n) = (1 + µ cos(ωmn)) cos(ωcn) (11)
where fc = ωc/2π is the carrier frequency, fm = ωm/2π is the
modulation frequency, and µ ∈ [0, 1] is the modulation index.
Fig. 2 shows an example where the characteristics of the respi-
ratory flow signal and the AM signal are quite similar.
Fig. 3. (a) Simulated AM signal with 0.3-Hz carrier frequency, 0.02-Hz mod-
ulation frequency, and µ = 1, (b) its correntropy function and (c) correlation
function. The CSD obtained with (d) Yule–Walker’s method and (f) Welch’s
method. The PSD obtained with (e) Yule–Walker’s method and (g) Welch’s
method.
C. Data Analysis
The accuracy of the proposed parameters for pattern char-
acterization is evaluated in terms of the following three classi-
fication problems: CHF patients with either PB or nPB, CHF
patients versus healthy subjects, and nPB patients versus healthy
subjects. Using a linear classification procedure, a parame-
ter selection process, being based on the leave-one-out cross-
validation, is employed in which only the single most discrimi-
native parameter is considered.
IV. RESULTS
The global AR model order was found to be 30 when the
aforementioned selection procedure was applied. Applying the
Ljung–Box test, the residuals of all 61 signals except two were
found to be whitened by the global AR model. The sole design
parameter of the method is σ, here determined by Silverman’s
rule in (6), and is investigated below for some deviating values.
In order to make the figures comparable, the scales have been
normalized to unity.
A. Simulated Signals
Fig. 3 illustrates the performance of the aforementioned meth-
ods in terms of power spectrum of the AM signal. From this
figure, it is evident that the spectra based on either correntropy
or correlation have very different characteristics, the main dif-
ference being the location of fm . For the correntropy-based
spectra, fm is found in the baseband and fc is accompanied
with a number of harmonics. For the correlation-based spec-
tra, the peaks are located at fc , fm − fc , and fm + fc , respec-
tively, as suggested by classical AM analysis. Note though that
Welch’s method is unable to resolve the two peaks at fm − fc
and fm + fc [see Fig. 3(e)]; no harmonic pattern is present in
the correlation-based spectra. Thus, correntropy-based spectra
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Fig. 4. (a) Simulated AM signal (0.3-Hz carrier frequency, 0.02-Hz mod-
ulation frequency, and µ = 1) with some outliers randomly added, (b) its
correntropy function and (c) correlation function. The CSD obtained with
(d) Yule–Walker’s method and (f) Welch’s method. The PSD obtained with
(e) Yule–Walker’s method and (g) Welch’s method.
has the advantage of exhibiting peaks at the positions of fm and
fc , which are easy to detect. On the other hand, the sideband
peaks of the correlation-based spectra can be difficult to detect
as they tend to smear with the respiratory peak at fc .
Fig. 4 illustrates the robustness of the correntropy technique
by adding randomly occurring impulsive noise to the AM signal
analyzed in Fig. 3. It is noted that the modulation peaks present
in Fig. 3(e) can no longer be discerned in Fig. 4(e).
B. Real Signals
Spectral analysis is also performed on signals from CHF
patients (see Figs. 5–7) and a healthy subject (see Fig. 8) for
the purpose of illustrating differences in respiratory patterns. In
both types of spectra, the respiratory peak is clearly visible. The
correntropy-based spectra of the healthy subject [see Fig. 8(d)]
lacks a peak corresponding to the modulation frequency, unlike
the spectra of CHF patients. The PB patients present much
more prominent modulation peaks [see Figs. 5(d) and 6(d)]
than does the nPB patient [see Fig. 6(d)]. It is evident from these
examples that the modulation frequency peak is easily detected
in the correntropy-based spectra, but not in the correlation-based
spectra. In fact, the latter type of spectrum does not even lend
itself to sideband peak detection.
C. Sensitivity to σ
The choice of σ is illustrated for an AM signal and a flow
signal using the CSD, see Fig. 9. The σ-value is chosen with
reference to the optimal value σopt given by Silverman’s rule.
For the AM signal, it is obvious that the power of the modulation
peak decreases as σ increases, i.e., 10σopt , whereas the power of
the spurious harmonics increases as σ decreases, i.e., 0.1σopt .
When considering these three σ-values, the two peaks of interest
are most easily detected for σopt . For the flow signal, a similar
Fig. 5. (a) Respiratory flow signal of a CSR patient, (b) its correntropy func-
tion, and (c) correlation function. (d) CSD and (e) PSD, both obtained with
Yule–Walker’s method.
Fig. 6. (a) Respiratory flow signal of a CHF patient with PB, (b) its correntropy
function, and (c) correlation function. (d) CSD and (e) PSD, both obtained with
Yule–Walker’s method.
behavior is observed though the changes in spectral shape are
less pronounced for different values of σ than what is observed
for the AM signal.
D. Performance Evaluation
Table II presents the mean and the standard deviation of the
most relevant parameters, for each group of patients and healthy
subjects. Table III shows the classification results obtained when
only the most discriminative parameter was applied. The corren-
tropy mean V provides the best results when classifying CHF
patients versus healthy subjects and nPB patients versus healthy
subjects, (95.2% and 94.4%, respectively). When classifying
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Fig. 7. (a) Respiratory flow signal of a CHF patient with nPB, (b) its corren-
tropy function, and (c) correlation function. (d) CSD and (e) PSD, both obtained
with Yule–Walker’s method.
Fig. 8. (a) Respiratory flow signal of a healthy subject, (b) its correntropy
function, and (c) correlation function. (d) CSD and (e) PSD, both obtained with
Yule–Walker’s method.
PB and nPB patients within the CHF group, only the spectral
power-related parameters were found to produce good results,
providing an accuracy of 88.9%.
The sensitivity to different values of σ is evaluated as before
for 0.1σopt , σopt , and 10σopt with respect to the three classifi-
cation tasks involving only the most discriminative parameter.
Table IV presents the area under the receiver operating charac-
teristic (ROC) for the three different classification tasks: it is
obvious that the choice of σ is not critical for the classifica-
tion as the area under the ROC is essentially unchanged for the
different values of σ.
Fig. 9. (a) Simulated AM signal and (b) respiratory flow signal of a PB patient.
Their respective (c)–(d) PSDs and (e)–(f) CSDs evaluated for the kernel values
0.1σopt , σopt , and 10σopt .
TABLE II
MEAN AND STANDARD DEVIATION OF V AND R FOR EACH
GROUP OF SUBJECTS*
TABLE III
SENSITIVITY (SN), SPECIFICITY (SP), AND ACCURACY (ACC) OBTAINED
WITH THE BEST PARAMETER FOR EACH CLASSIFICATION USING
LEAVE-ONE-OUT CROSS-VALIDATION
TABLE IV
SENSITIVITY OF THE KERNEL PARAMETER σ IN TERMS OF AREA UNDER THE
ROC OBTAINED FOR THE BEST PARAMETER FOR EACH CLASSIFICATION
V. DISCUSSION
This paper investigates the use of correntropy for spectral
characterization of respiratory patterns in CHF patients. In con-
trast to the conventional second-order correlation function, the
correntropy function accounts for higher order moments and is
robust to outliers. In this study, the former property translates to
1970 IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING, VOL. 57, NO. 8, AUGUST 2010
the fact that the respiratory and modulation frequencies appear
at their actual locations along the frequency axis in the CSD; see
the Appendix for an explanation of this property. Hence, the cor-
rentropy circumvents problems that may arise when identifying
the modulation frequency peak directly from the conventional
PSD due to insufficient spectral resolution; this problem is il-
lustrated for the simulated AM signal in Fig. 3. In the same
sense, the use of correntropy eliminates the demodulation step,
which was an integral part of our previous studies [19], [20], be-
ing introduced so that respiratory periodicity could be detected
from the envelope of the flow signal with time-frequency analy-
sis. In those two studies, various parameters were derived from
the time-frequency representation and employed for classifying
respiratory patterns in CHF patients. Using a three-parameter
procedure, which involved the AR coefficients, an accuracy of
84.6% was achieved when classifying PB and nPB patients [20].
Obviously, that result is inferior to the one achieved here with
an accuracy of 88.9%, see Table III. While this improvement
is perhaps not dramatic it is still of importance as the present
classification is based on only one parameter instead of three.
The inferior result of the previous study was primarily due to
difficulties in identifying the modulation frequency.
Another attractive property of the correntropy function is its
robustness against outliers, explained by the fact that the inner
product is computed via the Gaussian kernel in the parameter
space, which tends to zero when outliers occur. Such robust-
ness is essential in the analysis of respiratory signals since they
are frequently corrupted with noise and spike artifacts. For the
present study, this property has implied that the preprocessing
required for outlier rejection in our previous studies, [19], [20],
could be completely eliminated without impairing classification
performance. Accordingly, the present method is considerably
more efficient from a computational viewpoint than our previous
methods.
The choice of σ was found to be uncritical as rather large
changes in value did not alter performance much. Using Silver-
man’s rule, the performance in terms of sensitivity and speci-
ficity remained essentially the same even if the value was ten
times larger or ten times smaller compared to the value given by
the rule, see Table IV. A further increase of σ causes however
the importance of higher-order moments to decay much faster
so that the correntropy approaches the second-order correlation,
whereas a further decrease in σ leads to meaningless spectral
estimation.
It should be noted that the proposed method is very simple in
structure because σ constitutes the only design parameter. The
model order, which by some would be treated as a design pa-
rameter [31], [30], was held fixed for all subjects once estimated
from the dataset. The chosen model order of 30 turns out to be
less critical as classification performance was virtually identical
when orders between 25 and 35 were used instead.
The main goal of this study has been to identify CHF patients’
condition noninvasively by characterizing and classifying respi-
ratory flow patterns that derive from patients with PB and nPB.
The best results were, in general, achieved with CSD-related pa-
rameters characterizing the power in ∆fm and ∆fr , i.e., Pm and
R. These parameters achieved the best results in all classifica-
tions performed with CHF patients consisting of CSR patients,
PB patients without apnea, and nPB patients. It should be noted
that all patients, i.e., both PB and nPB, exhibit various degrees
of periodicity depending on their condition, whereas the healthy
subjects have no pronounced periodicity.
Since patients with PB patterns exhibit a larger modulation
peak in proportion to the respiratory peak than do nPB patients,
the ratio between the power in the modulation band and respi-
ration band is a suitable parameter for classifying PB and nPB
patients. The promising classification results are explained by
the fact that the CSD provides a more clear-cut representation of
the modulation peak than does the PSD. In general, CHF patients
present an increased amplitude on ventilation and therefore on
their respiratory flow signal. Since the correntropy is based on
the distance between samples, the correntropy mean turns out to
be higher in healthy subjects than in the CHF patients. It provides
excellent classification results in the classification of CHF and
healthy subjects, as well as of nPB patients and healthy subjects,
CHF verus healthy 95.2%, and nPB versus healthy 94.4%).
The main goal of most studies on breathing patterns in CHF
patients differ from the present one as other studies are focused
on the prediction of mortality, e.g., by exploring the properties
of heart rate variability with linear [32], [33] and nonlinear
techniques [34]. Consequently, it is difficult to compare the
present results with those obtained in other studies.
The small size of the dataset is a limitation of the present
study, and therefore the significance of the results, though being
promising, needs to be further established on a larger set. As a
consequence of the small size, it was decided to only investigate
the performance of single-parameter linear classification.
VI. CONCLUSION
In this study, the correntropy-based spectral density is found
to be particularly well suited for the characterization of mod-
ulated breathing patterns. Three different spectral parameters
are defined, which characterize the power in the respiratory and
modulation frequency bands and their proportion. The spectral
estimation method is simple as very few design parameter values
need to be set. However, research is needed to better understand
how the eigenstructure of the correntropy matrix influences the
estimation of AR parameters. Simulations with an AM signal
demonstrate that the correntropy approach comes with much
better spectral resolution than does the conventional techniques.
Though this study is preliminary in nature, the classification
results on a clinical dataset, containing respiratory flow sig-
nals from CHF patients and healthy subjects, are promising as
they surpass earlier results obtained for a demodulation-based
method.
APPENDIX
This appendix offers an explanation to why the correntropy
makes the respiratory and modulation frequency peaks more
discernible without requiring demodulation. The starting point
is the AM signal,
x(n) = (1 + µM(n))C(n)
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Fig. 10. (a) AM signal and (b) its correntropy function, using σ given by
Silverman’s rule, and (c) its correlation function.
where M(n) = cos(ωmn) and C(n) = cos(ωcn). The corre-
sponding correlation function is given by
Rx(n) = (1 + µ2RM (n)) cos(ωcn)
where RM (n) denotes the correlation function of M(n). Thus,
Rx(n) is proportional to RM (n), being modulated by ωc .
On the other hand, it can be shown that the corren-
tropy function of x(n) is proportional to both VM (n) and
VC (n). For a Gaussian kernel, VM (n) reaches its maxi-
mum only when M(n) = M(n + m). When this occurs, we
have that κ(xn − xn−m ) = 1/
√
2πσ, and M(n) = M(n +
m)→ cos(ωmn) = cos(ωm (n + m)), ⇔ mωmn = 2πk, k =
1, 2, . . .. The maximum values are obtained when m = mm =
2πk/ωm = TmFsk, where Fs is the sampling rate and Tm is
the modulation period. The correntropy VM (n) reaches its max-
imum for each mm and decreases rapidly when the difference
M(n)−M(n + m) increases. For VC (n), the maximum val-
ues are reached when m = mc = 2πk/ωc = TcFsk, where Tc
is the carrier period.
The correntropy function V (n) reaches its maximum when m
is a multiple of both Tm and Tc , whereas the relative maximum
values are reached when m = mc . As ωm ≤ ωc → Tm ≥ Tc →
mm ≥ mc . Thus, the maximum value is given by the modulation
signal (mm ).
Only when both periods are multiples, i.e., Tm = kTc is
the maximum value 1/
√
2πσ reached, otherwise this value is
lower. The maximum value appears in each modulation period,
explaining why the modulation frequency peak is sometimes
larger than the respiratory frequency peak. Thus, it can be stated
that correntropy enhances the modulation peak. Fig. 10 demon-
strates the property thatRx(n) ∝ RM (n) is modulated byC(n),
whereas V (n) ∝ γVM (n) + βVC (n), where γ and β are posi-
tive constants.
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